Rates of Major Bleeding With Rivaroxaban in Real-World Studies of Nonvalvular Atrial Fibrillation Patients: A Meta-Analysis.

Rates of Major Bleeding With Rivaroxaban in Real-World Studies of Nonvalvular Atrial Fibrillation Patients: A Meta-Analysis. Curr Med Res Opin. 2016 Mar 2;:1-11 Authors: Weeda ER, White CM, Peacock WF, Coleman CI Abstract Numerous real-world studies estimating major bleeding rates in rivaroxaban patients with nonvalvular atrial fibrillation have been published. We performed a meta-analysis to better quantify the rates of different types of major bleeding seen with rivaroxaban in observational studies. The pooled rates of major bleeding with rivaroxaban were generally low and consistent with those reported in its pivotal randomized controlled trial. PMID: 26934003 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research